drugset / Trial / NCT04685811
Evaluation of PSMA Antagonist Produced by Two Different Methods
Phase 1/2
Completed
16 enrolled
Weill Medical College of Cornell University
National Cancer Institute (NCI) · collabNational Institutes of Health (NIH) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Patients with metastatic prostate cancer will undergo two protocol 68Ga-PET scans within 24-48 hours with 68Ga-PSMA-cyclotron and 68Ga-PSMA-generator radiotracers. The goal of the study is to evaluate repeatability and equivalence across the different 68Ga-PSMA production methods. This research study is being conducted to assess whether the PET/CT imaging results, as generated from the two different 68Ga production methods, are equivalent.
Timeline
- Start
- 2020-12-09
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-PSMA-cyclotron | Small molecule | — | — |
| Subject | 68Ga-PSMA-generator | Small molecule | — | — |